A study published in the BMJ this week (Kieler and colleagues, BMJ 2012: 344: d8012) has concluded that the newborn of women treated with SSRI* antidepressants in the second half of pregnancy have an increased risk of a rare condition – persistent pulmonary hypertension (PPH). 'It is important to recognise that, overall, the risk to babies is very small,' said Dr Rupert Sherwood.
For more information read the Antidepressant Use in Late Pregnancy & The Risk of Persistent Pulmonary Hypertension in the Newborn media release.
